Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molecular Products is a commercial-stage manufacturer of life-critical breathable-gas treatment products used across healthcare, defense, diving, industrial safety, mining, and gas-processing markets. The company is best known for carbon dioxide absorbents used in anesthesia and rebreather systems, activated carbon filtration media, solid oxygen systems, and specialty catalysts and zeolites. Rather than operating as a therapeutics developer, it sells mission-critical products and custom chemical media solutions that help remove toxic gases, sustain breathable atmospheres, and provide supplemental oxygen in constrained environments. The business has an international footprint with operations in the UK, US, Asia, and India, and it now operates as part of Filtration Group, an affiliate of Madison Industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molecular Products Group.